Research Papers

4 of 1604 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Regulation of immunotherapeutic products for cancer and FDA's role in product development and clinical evaluation.
Vatsan RS; Bross PF; Liu K; Theoret M; De Claro AR; Lu J; Helms W; Niland B; Husain SR; Puri RK.
J Immunother Cancer (Unknown)
Published: 2013
1/6 Transparent
Essential complicity of perforin-granzyme and FAS-L mechanisms to achieve tumor rejection following treatment with anti…
Morales-Kastresana A; Catalán E; Hervás-Stubbs S; Palazón A; Azpilikueta A; Bolaños E; Anel A; Pardo J; Melero I.
J Immunother Cancer (Unknown)
Published: 2013
2/6 Transparent
Funding Declared
Presence of antigen-specific somatic allelic mutations and splice variants do not predict for immunological response to…
Becker JT; McNeel DG.
J Immunother Cancer (Unknown)
Published: 2013
2/6 Transparent
Funding Declared
Immune evasion in acute myeloid leukemia: current concepts and future directions.
Teague RM; Kline J.
J Immunother Cancer (Unknown)
Published: 2013